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Selective recognition of the di/trimethylammonium motif by an 
artificial carboxycalixarene receptor   
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Kawamura,b Vijayalekshmi Sarojini,c Ivanhoe K. H. Leung*c and Tobias Gruber*a, §
Chemical tools that recognise post-translational modifications have 
promising applications in biochemistry and in therapy. We report a 
simple carboxycalixarene that selectively binds molecules 
containing di/trimethylammonium moieties in isolation, in cell 
lysates and when incorporated in histone peptides. Our findings 
reveal the potential of using carboxycalixarene-based receptors to 
study epigenetic regulation. 
Post-translational modifications (PTMs) are chemical 
alterations to proteins that occur after their biosynthesis in 
ribosomes.1 PTMs often play important biological roles, 
including in protein folding, signalling and epigenetic regulation 
of transcription. However, despite their functional importance, 
the underlying mechanisms by which PTMs induce their 
biological functions are largely undefined, thus hindering 
biomedical efforts. This is particularly pertinent in the field of 
epigenetics, where transcriptional control is likely induced by 
combinations of PTMs, predominantly on the N-terminal tail of 
histone H3, in a highly context-dependent manner.2 
Deciphering the functional roles of PTMs relies on bio-
chemical/biological methods that enable the recognition and 
discrimination of specific PTMs. In this regard, the majority of 
reported studies use antibodies;3 however, antibodies are often 
sub-optimal PTM binders in these experiments due to (often) 
incomplete characterisation of their binding profiles/selectivity, 
their propensity to undergo unfolding/ degradation, their 
relatively high cost and batch-to-batch variations in their 
binding affinities to their targets. Chemical tools that selectively 
recognise PTMs represent a promising alternative to antibodies 
and have found applications in biochemical and cellular activity 
and binding assays, and in biomedical applications including 
disease diagnostics.4 
We are interested in developing molecules, i.e. artificial 
receptors, that selectively recognise and bind PTMs, with a 
particular focus on developing binders of methylated lysines. 
Lysine Nε-methylation, which exists in mono-, di- and tri-
methylated forms, occurs at multiple positions on histones and 
is often reported to either induce or repress gene expression by 
mechanisms that are dependent on the locations and extent of 
methylation.5 However, the precise mechanisms by which these 
effects are induced and propagated remain largely 
uncharacterised. Furthermore, the enzymes that deposit and 
remove histone lysine methyl groups (lysine methyltransferases 
and lysine demethylases respectively), as well as proteins that 
bind to methylated histone lysines (e.g. plant homeobox 
domain- and chromodomain-containing proteins), are 
important therapeutic targets, particularly in cancer.6 However, 
medicinal chemistry efforts in this field are hampered by a lack 
of suitably robust activity and binding assays that can report the 
methylation states of histone lysines.  
 
Fig. 1 Synthesis of carboxycalixarene 1. Initial treatment of the commercially 
available calix[4]arene with 1,1-dichlorodimethylether and tin(IV)chloride afforded the 
aldehyde intermediate 2. This is oxidized using sulphamic acid and sodium chlorite to 
yield monoacid 1. 
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In general, the recognition and binding of amino acids, 
oligopeptides and proteins by artificial receptors under 
physiological conditions, viz. in aqueous solution, has always 
been a challenging task in supramolecular chemistry. As many 
peptides and proteins contain amino acids with basic side 
chains, which are positively charged under neutral conditions, 
their recognition is in most cases ascribable to the complexation 
of alkylammonium ions.7 Besides steric and molecular 
complementarity, three types of interactions between host and 
guest are typical: a) Hydrogen bonds, b) Cation···π-interactions, 
c) Ion pairs and salt bridges.8 Using this concept, a large variety 
of artificial ammonium ion receptors have been introduced, 
ranging from crown ethers, cyclopeptides and calixarenes to 
molecular tweezers, cucurbiturils and cyclodextrins.9 Early work 
on this topic was limited to recognition of ammonium ions in 
organic solvents, allowing strong hydrogen bonding between 
host and guest. In recent years, some progress has been made 
concerning the complexation of amino acids and peptides in 
more polar solvents, such as methanol and especially in water.10 
In this more challenging medium, hydrogen bonding between 
host and guest will provide less impetus for binding.11 As 
introduction of methyl groups to basic amino acid residues 
results not in a change of the overall charge but in more 
lipophilic side chains, C-H∙∙∙π interactions and the hydrophobic 
effect are having a substantial reinforcing effect on the 
complexation.  
 
Fig. 2 Small molecules tested in this study. These include trimethyllysine (3), 
dimethyllysine (4), acetylcholine (5), choline (6), carnitine (7), meldonium (mildronate) 
(8), 4-dimethylaminopyridine (9), methyllysine (10) and lysine (11). Unless otherwise 
specified, racemic compounds are used in this study. 
When dealing with the recognition of biologically active species, 
like amino acids and peptides featuring post-translational 
modifications, the artificial host provides a ‘‘minimized’’ 
representation of the binding sites of natural receptors. 
Focusing on methylated amino acid residues here structural 
studies on methyllysine effectors in cognate peptide–bound or 
apo forms suggest general mechanisms that are used by binding 
pockets to achieve specificity toward distinct methylation 
states; for recognizing di- and trimethylated lysine residues, 
“aromatic cages” are typical.12 Such cavities can be mimicked by 
aromatic macrocycles, which already delivered promising 
results for a great variety of guest compounds such as lipids, 
nucleotides and (unsubstituted) amino acids and peptides.13 
One particular class are so-called calix[4]arenes i.e. m-
cyclophanes with four phenolic groups, featuring electron-rich 
aryl moieties.14 The inclusion properties of differently 
substituted calix[4]arenes towards amines and ammonium ions 
are well-established. Thereby, very often ionisable groups, such 
as carboxylic or sulfonic acids, have been introduced to the 
macrocylce.15 Due to the rigid multiaromatic cavity and charge 
complementarity this artificial hosts can be also applied to 
imitate the natural aromatic cages found in lysine modifying 
enzymes. The inclusion behavior of calixarenes depends 
profoundly on their conformation, their substitution pattern 
and the solvents employed for inclusion formation, with some 
examples discussed in the following for carboxylated 
calix[4]arenes. Respective cycles with free OH groups16 and 
double alkylated17 species feature very often a so-called ‘cone’ 
conformation with an open cavity facilitating C-H∙∙∙π 
interactions between host and guest. Tetralkylation of the 
phenolic moieties mostly leads to a closed cavity making guest 
inclusion into the cavity difficult;18 an exception are tetra-
methoxy and tetraethoxy calix[4]arenes as they show a much 
higher conformational flexibility.19  
 
Fig. 3 NMR analysis of the binding of trimethyllysine 3 to carboxycalixarene 1. (a) 
Relative changes of chemical shifts of trimethyllysine 3 in the presence and absence of 
carboxycalixarene 1. The hash symbol (#) indicates resonance of residue DMSO-d6 and 
the asterisk (*) indicates an impurity in 1; (b) Binding epitope mapping of trimethyllysine 
3 showing changes in chemical shifts (and relative percentage) upon binding to 
carboxycalixarene 1. 
Herein we present a simple, easily synthesised monocarboxy-
calix[4]arene (1) in the cone conformation that binds 
methylated lysines. This compound is related to, but is distinct 
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from, previously reported methyllysine binders.20 Carboxy-
calixarene 1 was synthesised from aldehyde 2 by applying a 
Gross formylation21 followed by oxidation with sodium chlorite 
(Fig. 1 and Supplementary Information).22,23 
The binding of 1 to a library of methylammonium-containing 
compounds (Fig. 2) was then studied using 1H NMR. Initial 
screening was conducted with 250 μM of carboxycalixarene 1 
and a 2-fold excess of potential ligand (500 μM) to ensure the 
detection of intermolecular binding interactions. Out of the 
nine compounds screened, carboxycalixarene 1 was found to 
selectively bind compounds that contain the dimethyl-
ammonium and trimethylammonium moieties (compounds 3–
9), as evidenced by significant changes in the N-methyl chemical 
shift, and in some cases, changes in peak width. No or very little 
spectral changes (≤0.01 ppm) were observed for compounds 
containing only amine or mono-methylammonium moieties 
(compounds 10 and 11; Supplementary Fig. S3–S11), indicating 
no or very weak binding to 1. The relative chemical shift changes 
of the di- and trimethylammonium-containing compounds were 
then mapped onto their structures (Fig. 3); by comparing 
relative perturbations in chemical shifts, binding epitopes of the 
small molecules to carboxycalixarene 1 were determined. With 
trimethyllysine 3, the most significant chemical shift 
perturbations were observed in resonances corresponding to 
the Nε-methyl groups (0.12 ppm). The perturbation observed 
for the ε-CH2 resonance was 0.07 ppm, which is 60% relative to 
the Me3 signal perturbation, and no change was observed for 
the -proton, which is far removed from the 
trimethylammonium group, suggesting that 1 selectively 
recognises and interacts with the trimethylammonium group of 
trimethyllysine (Fig. 3b). Epitope mapping of compounds 4–9 
shows the same selective recognition of 1 to the 
dimethylammonium and trimethylammonium motifs 
(Supplementary Fig. S12–S17). 
Table 1 Dissociation constants, KD, of the small molecule library screened in this study 
with carboxycalixarene 1 and tetrasulfonatocalixarene.24 
Guest 
KD – Host: 
Carboxycalixarene 1 
KD – Host: 
Tetrasulfonatocalixarene 
3 60 ± 10 μM 27 μM [c] 
4 70 ± 5 μM 62 μM [c] 
5 n.d.[a] - 
6 65 ± 5 μM - 
7 60 ± 15 μM - 
8 50 ± 1 μM - 
9 95 ± 10 μM - 
10 > 500 μM [b] 250 μM [c] 
11 > 500 μM [b] 1900 μM [c] 
[a] KD cannot be determined as 5 was unstable under assay condition. [b] No or 
little (<0.01 ppm) chemical shift changes observed under experimental conditions. 
KD cannot be estimated precisely due to limited solubility of carboxycalixarene 1. 
[c] Ref. 24 
Titration experiments were then conducted to determine the 
binding constants (KD) for carboxycalixarene 1 and the small 
molecule binders identified by NMR. Apart from 9, which is 
aromatic in nature, all KD values obtained were around 60 μM 
with no discernible preference between dimethylammonium 
and trimethylammonium moieties (Table 1, Supplementary Fig. 
S18–S23). Due to the limited solubility of 1, it was not possible 
to obtain binding constants for compounds 10 and 11, which 
showed no or very little chemical shift changes (≤0.01 ppm) 
upon addition of 1 in the initial NMR experiments. Interestingly, 
in contrast to other reported methyllysine-binding macrocycles 
like tetrasulfonatocalixarene,24 carboxycalixarene 1 has a 
similar affinity to Kme3 and Kme2 and is selective over Kme1 
and Kme0, which is different to the selectivity profile of the 
reported tetrasulfonatocalixarene. 
 
Fig. 4 Energy-minimised complexes of carboxycalixarene 1 with lysines of different 
methylated states (a-d). In the lysine and monomethyllysine complex, the positively 
charged nitrogen is pointing away from the cavity; the ε-ammonium moieties of 
dimethyllysine and trimethyllysine were found to be accommodated in the calixarene 
cavity. (The host was introduced as an anion, the guests as zwitterions with the Nε as an 
ammonium ion. For the C-H∙∙∙π-interactions the centroids of the aromatic rings or the 
centroids of two respective carbo atoms have been used. The energy minimization has 
performed with the programme MacroModel V.9.8 using the following parameter: 
OPLS_2001 force field, MCMM, solvent: water, 20,000 steps.) 
In order to gain insights into the molecular interactions of 1 with 
dimethylammonium and trimethylammonium moieties, 
molecular modelling studies were conducted. Energy-
minimised complexes of 1 with the four lysine binders 
(compounds 3, 4, 10 and 11) were obtained using Monte Carlo 
simulations employing the OPLS_2001 force field (MacroModel 
V.9.8, solvent: water, 20,000 steps, Fig. 4 and Supplementary 
Table 1).25 Interestingly, the side chains of dimethyllysine 4 and 
trimethyllysine 3 were found to be accommodated within the 
host, with the ε-ammonium moieties pointing into the 
calixarene cavity; for lysine and monomethyllysine, it is pointing 
away from the cavity. This suggests that cation∙∙∙π-
interactions26 contribute to the recognition between 1 and 
dimethyllysine or trimethyllysine. Furthermore, four [d(H∙∙∙π) = 
2.654–3.023 Å] and five [d(H∙∙∙π) = 2.778–2.944 Å] C-H∙∙∙π-
interactions were observed between 1 and dimethyllysine 4 and 
trimethyllysine 3 respectively, suggesting all N-methyl groups 
interact with 1. By way of interest the X-ray structure of a 
tetrasulfonato-calix[4]arene/lysine complex27 shows a very 
similar orientation of the lysine in the cavity of the host as the 
respective complex of lysine with 1. Crystalline inclusion 
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compounds of higher alkylated ammonium ions with 
calix[4]arenes are much rarer. Very often the tetraalkylation of 
the phenolic groups leads to closed cavities preventing the 
ammoniumion entering the molecular cavity.28 Though, 
tetrasulfonato-calixarenes with free phenol moieties were 
found to form respective complexes with the opened chalice 
facilitating C-H∙∙∙π and cation∙∙∙π interactions between host and 
guest together with the ammonium ion/sulfonate ion pair.29 By 
way of interest, also one of the phenolic OH groups of 
undecorated calix[4]arenes can get ionized to form complexes 
with tetra- and trialkylammonium ions. Thereby, acetonitrile as 
a solvent was found to compete with the alkyl groups in the 
formation cavity inclusions and respective C-H∙∙∙π 
interactions.30    
Table 2 Dissociation constants, KD, of H3 peptide fragments with carboxycalixarene 1 
H3 peptide fragments KD with 1 
PATGGV(Kme1)KPHRY > 500 μM [a] 
PATGGV(Kme2)KPHRY 60 ± 1 μM 
PATGGV(Kme3)KPHRY 65 ± 5 μM 
AR(Kme1)STGGK > 500 μM [a] 
AR(Kme2)STGGK 50 ± 5 μM 
AR(Kme3)STGGK 50 ± 2 μM 
[a] No or little (<0.01 ppm) chemical shift changes observed under experimental 
conditions. KD could be estimated due to limited solubility of carboxycalixarene 1. 
Having identified binding between 1 and methylammonium-
containing small molecules, experiments were conducted to 
determine whether 1 can recognise di/trimethyllysine residues 
within biologically relevant fragment peptides. Two histone H3 
peptide fragments corresponding to residues 7-14 and 30-41 
(sequence = AR(K9)STGGK and PATGGV(K36)KPHRY 
respectively) and containing trimethyllysine, dimethyllysine and 
monomethyllysine at residues 9 and 36 respectively, were 
synthesised and purified before binding analyses using 1H NMR. 
H3K9 methylation are generally associated with repressive 
genes, whereas H3K36 methylation is thought to correlate with 
transcriptional activation. In agreement with the small molecule 
studies, 1 was found to selectively recognise peptides 
containing dimethyllysine or trimethyllysine residues over those 
containing monomethyllysine residues (Supplementary Fig. 
S24–S29). KD values between 1 and the dimethyllysine and 
trimethyllysine-containing peptides, obtained by 1H NMR 
titration experiments, were comparable to the KD values for 1 
and dimethyllysine and trimethyllysine (Table 2 and 
Supplementary Fig. S30–S33). 
Finally, we tested the binding of 1 to small molecules that 
contain the di/trimethylammonium moiety in Escherichia coli 
cell lysates representing a complex analytical matrix. Bacterial 
cells were grown at 37 °C overnight before harvesting and lysing 
using sonication. After centrifugation and filtration, the cell 
lysate was supplemented with 450 μM of dimethylammonium 
and trimethylammonium-containing small molecules. Using 1H 
NMR, the binding of the spiked compounds to 1 was clearly 
observed, revealing the potential for 1 to identify methylated 
species in complex mixtures (Fig. 5 and Supplementary Fig. S34–
S37).  
 
Overall, a simple, readily produced monocarboxycalix[4]arene 
(1) that selectively binds to di/trimethylammonium groups is 
presented. 1 was observed to discriminate between di-/tri- and 
mono/non-methylated lysines as free amino acids and when 
incorporated into histone fragment peptides. Our results 
indicate 1 to be a useful chemical tool to analyse differentially 
methylated lysines in biochemical and potentially cellular 
assays. In addition, it is also potentially useful in, for example, 
the monitoring and study of agricultural waste, which usually 
contains methylammonium ion moiety-containing compounds. 
Furthermore, molecular modelling studies suggest that 1 binds 
methylammonium groups via π-cation interactions, revealing 
potential avenues for synthetic optimisation. The research 
presented here will help in the development of libraries of 
synthetic methyllysine receptors useful in biochemical, cellular 
and potentially therapeutic applications.  
 
Fig. 5 Carboxycalixarene 1 recognised and bound 3 in cell lysates, as indicated by 
changes in the N-Me resonance chemical shift of 3 (blue to orange). The other signals in 
the spectrum are metabolites and molecules from the cell lysate. 
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